Just before the PDT, we defined the tumor margin accurately using the novel PDD system SAFE-3000 with NPe6 and a diode laser (408 nm). Results: Red fluorescence emitted from the tumor by excitation of the photosensitizer by the diode laser (408 nm) from SAFE-3000 allowed accurate determination of the tumor margin just before the PDT. The complete remission (CR) rate following NPe6-PDT in the cases with early lung cancer was 93.3% (42 /45 lesions). We also confirmed the loss of red fluoresce from the tumors immediately after the PDT using SAFE-3000. We confirmed that all the NPe6 in the tumor had been excited and photobleached by the laser irradiation (664 nm) and that no additional laser irradiation was needed for curative treatment.
Conclusions: This novel PDD system using SAFE-3000 and NPe6 improved the quality and efficacy of PDT and avoided misjudgment of the dose of the photosensitizer or laser irradiation in PDT.
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Chest Medicine, Wed, 10:30 -12:15 evaluation of radiofrequency ablation for thoracic malignancies using PDG-PET-CT scan Background: Radiofrequency ablation therapy (RFA) is widely applied for the treatment thoracic malignancies as a modality of local control therapy lately. RFA procedure itself is thought to be almost safe. However, assessment of therapeutic efficacy following RFA procedure is not well established. Lately, the use of FDG-PET-CT scan has been advocated for early tumor diagnosis or early recurrent cancer detection in the field of thoracic malignancies. Although several studies showing the benefit of FDG-PET-CT scan in RFA for thoracic malignancies have been reported, optimal timing of examinations after RFA, appropriate fol-
